Cardiovascular Risk

ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation

LDL Cholesterol Reduction Following Ezetimibe Initiation

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Artificial Intelligence - Based Opportunistic Coronary Artery Calcium Scoring on Routine Chest-CT Scan

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Huangqi Gegen Decoction for Endothelial Function in Type 2 Diabetes at Very High ASCVD Risk

Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome

Precision Study of CLAiR AI Software

Predication of Arterial Stiffness in Healthy Adults by Oral Health and Chewing Assessments

Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP)

Dose-Response to Resistance Exercise on Cardiovascular Health

Prevalence and Overlap of Cardiovascular, Kidney, and Metabolic Diseases in Korea: A Population-based Study

Cardiovascular Risk in Patients With IBD

AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images

Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors

Evaluation of Cardiovascular Risks Among the Participants of the ESC Congress 2025

Interdisciplinary Program to Improve Lifestyle in Chronic Pathology: Alt Pirineu Aran in Fit (APA-FIT)

Cf-PWV and TyG Index Study

Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition in Japan.

Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension